DK1635692T3 - Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme - Google Patents

Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme

Info

Publication number
DK1635692T3
DK1635692T3 DK04776460.0T DK04776460T DK1635692T3 DK 1635692 T3 DK1635692 T3 DK 1635692T3 DK 04776460 T DK04776460 T DK 04776460T DK 1635692 T3 DK1635692 T3 DK 1635692T3
Authority
DK
Denmark
Prior art keywords
monitoring
inflammatory diseases
hematological
immunological
conditions
Prior art date
Application number
DK04776460.0T
Other languages
English (en)
Inventor
Joseph M Ahearn
Susan M Manzi
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK1635692T3 publication Critical patent/DK1635692T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04776460.0T 2003-06-13 2004-06-12 Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme DK1635692T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47849303P 2003-06-13 2003-06-13
PCT/US2004/018552 WO2004112572A2 (en) 2003-06-13 2004-06-12 Monitoring immunologic, hematologic and inflammatory diseases

Publications (1)

Publication Number Publication Date
DK1635692T3 true DK1635692T3 (da) 2010-08-09

Family

ID=33539102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04776460.0T DK1635692T3 (da) 2003-06-13 2004-06-12 Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme

Country Status (14)

Country Link
US (1) US8080382B2 (da)
EP (2) EP1635692B1 (da)
JP (2) JP2007501948A (da)
KR (1) KR20060015646A (da)
AT (1) ATE465275T1 (da)
AU (1) AU2004249155B2 (da)
CA (1) CA2529045A1 (da)
DE (1) DE602004026724D1 (da)
DK (1) DK1635692T3 (da)
ES (1) ES2342291T3 (da)
IL (1) IL172488A0 (da)
NO (1) NO20056013L (da)
WO (1) WO2004112572A2 (da)
ZA (1) ZA200510325B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60237529D1 (de) * 2001-09-10 2010-10-14 Univ Pittsburgh Diagnose und aufzeichnung von systemischem lupus erythematosus und von skleroderm
EP1618379B1 (en) 2003-04-16 2012-04-04 University of Pittsburgh - of the Commonwealth System of Higher Education Identification and monitoring of systemic lupus erythematosus
WO2005108988A2 (en) * 2004-04-09 2005-11-17 University Of Pittsburgh Real time method of detecting acute inflammatory conditions
EP1745287B1 (en) * 2004-05-11 2010-09-22 University of Pittsburgh - Of the Commonwealth System of Higher Education Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells
EP1934603A4 (en) * 2005-09-19 2010-01-06 Univ Johns Hopkins BIOMARKER FOR PROSTATE CANCER
WO2007095154A2 (en) 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
FR2899337B1 (fr) * 2006-03-31 2008-07-04 Univ Reims Champagne Ardenne Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation.
US7824874B2 (en) * 2006-05-25 2010-11-02 Litron Laboratories, Ltd. Method for measuring in vivo mutation frequency at an endogenous gene locus
EP2250485A1 (en) * 2008-03-04 2010-11-17 California Institute of Technology Methods of using optofluidic microscope devices
US8039776B2 (en) 2008-05-05 2011-10-18 California Institute Of Technology Quantitative differential interference contrast (DIC) microscopy and photography based on wavefront sensors
WO2009152428A1 (en) * 2008-06-12 2009-12-17 Litron Laboratories Ltd. Quantitative analysis of in vivo mutation at the pig-a locus
EP2347259A4 (en) * 2008-10-16 2012-02-29 Cypress Bioscience Inc METHOD FOR DIAGNOSIS AND MONITORING OF ILLICIT ACTIVITY AND RESPONSE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATODES (SLE) AND OTHER AUTOIMMUNE DISEASES
EP2380055A4 (en) 2009-01-21 2012-07-11 California Inst Of Techn QUANTITATIVE DIFFERENTIAL INTERFERENCE CONTRASTING DEVICE FOR COMPUTER-BASED DEEP-SECTIONING
US8416400B2 (en) 2009-06-03 2013-04-09 California Institute Of Technology Wavefront imaging sensor
KR101029004B1 (ko) * 2009-08-06 2011-04-14 강원대학교산학협력단 염증성 관절염 마커로서의 ｐｒｄｍ10 단백질 및 이를 포함하는 염증성 관절염 진단키트
WO2011119678A2 (en) 2010-03-23 2011-09-29 California Institute Of Technology Super resolution optofluidic microscopes for 2d and 3d imaging
CA2816423A1 (en) * 2010-11-02 2012-05-31 Kypha, Inc. Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
DK2643694T3 (da) 2010-11-24 2018-04-16 Litron Laboratories Ltd Hurtig in vivo-genmutationsassay baseret på pig-a-genet
CA2821067C (en) 2010-11-29 2019-06-04 Novelmed Therapeutics, Inc. Neoantibodies for diagnosing tissue injury
JP5990542B2 (ja) 2011-02-11 2016-09-14 エグザジェン ダイアグノスティクス インコーポレイテッドＥｘａｇｅｎ Ｄｉａｇｎｏｓｔｉｃｓ， Ｉｎｃ． 全身性エリテマトーデスのリスクスコアを算出する方法
JP5867834B2 (ja) * 2011-09-15 2016-02-24 株式会社島津製作所 肺癌マーカー補体Ｃ３ｄｇ分子及び肺癌マーカーの分析方法
ES2670661T3 (es) * 2012-03-29 2018-05-31 Proyecto De Biomedicina Cima, S.L. Nuevos marcadores moleculares de cáncer de pulmón
US20140155411A1 (en) * 2012-04-13 2014-06-05 Somalogic, Inc. Tuberculosis Biomarkers and Uses Thereof
EP2866821B1 (en) 2012-07-02 2018-11-14 Medizinische Universität Wien Complement split product c4d for the treatment of inflammatory conditions
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
JP2015535212A (ja) * 2012-08-17 2015-12-10 ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト 補体活性化を検出するための組成物および方法
RU2680270C2 (ru) 2013-02-08 2019-02-19 Аллегени-Сингер Рисерч Инститьют Клеточно-связанные продукты активации комплемента в качестве диагностических биомаркеров волчанки в доклинической стадии
US9863946B2 (en) 2013-02-08 2018-01-09 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
WO2014151238A1 (en) 2013-03-15 2014-09-25 Exagen Diagnostics, Inc. Methods for treating and diagnosing systemic lupus erythematosus
US20140335546A1 (en) * 2013-05-10 2014-11-13 G J Carroll Pty Ltd Devices and Methods for Determining the Risk of Developing a Serious Infection
JP6170865B2 (ja) 2014-03-31 2017-07-26 シスメックス株式会社 血液分析装置
WO2016015057A1 (en) * 2014-07-25 2016-01-28 The Trustees Of Dartmouth College Systems and methods for cardiovascular-dynamics correlated imaging
WO2016040314A1 (en) * 2014-09-08 2016-03-17 Yale University Compositions and methods for increasing red blood cells
JP6674543B2 (ja) 2015-07-31 2020-04-01 アレゲーニー・シンガー リサーチ インスティチュート 抗体に基づく薬物のコンパニオン診断としての細胞結合補体活性化産物アッセイ
CA3043251A1 (en) * 2016-12-09 2018-06-14 Gliknik Inc. Methods of treating inflammatory disorders with multivalent fc compounds
EP3361256A1 (en) * 2017-02-08 2018-08-15 Fundación para la Investigación Médica Aplicada In vitro method for the diagnosis of lung cancer
EP3771468A1 (en) * 2019-07-31 2021-02-03 Universitätsklinikum Hamburg-Eppendorf C3/c5 convertase assays

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
EP0739904A1 (en) 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
EP0814159B1 (en) 1990-08-29 2005-07-27 GenPharm International, Inc. Transgenic mice capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0666987A4 (en) 1992-10-30 1997-08-27 T Cell Diagnostics Inc EVALUATION OF THE TOTAL QUANTITY OF A MOLECULE IN A SAMPLE AND METHODS BASED ON SAME.
DE60237529D1 (de) 2001-09-10 2010-10-14 Univ Pittsburgh Diagnose und aufzeichnung von systemischem lupus erythematosus und von skleroderm
EP1618379B1 (en) 2003-04-16 2012-04-04 University of Pittsburgh - of the Commonwealth System of Higher Education Identification and monitoring of systemic lupus erythematosus

Also Published As

Publication number Publication date
JP2007501948A (ja) 2007-02-01
CA2529045A1 (en) 2004-12-29
EP1635692A4 (en) 2007-12-05
JP2010164581A (ja) 2010-07-29
AU2004249155B2 (en) 2009-11-19
ES2342291T3 (es) 2010-07-05
IL172488A0 (en) 2006-04-10
EP1635692A2 (en) 2006-03-22
EP2194383A1 (en) 2010-06-09
AU2004249155A1 (en) 2004-12-29
KR20060015646A (ko) 2006-02-17
EP1635692B1 (en) 2010-04-21
NO20056013L (no) 2006-03-10
WO2004112572A3 (en) 2005-06-02
ATE465275T1 (de) 2010-05-15
ZA200510325B (en) 2008-04-30
US20050042602A1 (en) 2005-02-24
US8080382B2 (en) 2011-12-20
WO2004112572A2 (en) 2004-12-29
DE602004026724D1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
DK1635692T3 (da) Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme
DK1745287T3 (da) Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
DK2021796T3 (da) Diagnose af hjerte-kar-sygdom
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
PL1836500T3 (pl) Sposoby i testy do rozróżniania między różnymi postaciami chorób i zaburzeń cechujących się małopłytkowością i/lub samoistną interakcją między czynnikiem von Willebranda (vWF) a płytkami krwi
CY1105322T1 (el) Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων
EA200500143A1 (ru) Азолидинонвинильные производные конденсированного бензола
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
BRPI0413058A (pt) material de amortecimento
SE0400191D0 (sv) A test kit for detecting periodontal disease
GB0512401D0 (en) Method
EP1756571B8 (en) Real time method of detecting acute inflammatory conditions
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
Iversen et al. Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
EP2322646A8 (en) Method of detecting platelet thrombosis or organ failure
FI20031370A0 (fi) Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
DE60234821D1 (de) Messverfahren für vollblut
WO2008041131A3 (en) Anticoagulant compounds
DK1406684T3 (da) Fremgangsmåde til at forøge pålideligheden af sporbarheden af blodprøver
Sthoeger et al. Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis
BR0317404A (pt) Variantes do fator xiia
DE60310655D1 (de) Kombination von CRP und D-Dimer zur Diagnose von tiefer Venenthrombose
ATE515576T1 (de) Protein c polymorphismen
WO2007075641A3 (en) Methods for assessing the pro-inflammatory immune health of an individual